Rockville, MD – July 28, 2010 – OriGene Technologies, Inc. a gene-centric life sciences company, today announced that through its July release, the TrueMAB™ monoclonal antibodies have reached the 3000 product milestone. (Full Press Release)
AACC Conference, Atlanta, GA and Rockville, MD July 24, 2011- OriGene Technologies, Inc., a gene-centric life sciencescompany known for its development cDNA clones, human full length proteins, antibodies, and other molecular tools for multiplex research introduces its major breakthrough technology High-Density Protein Microarray Chip for the quality control of its (TrueMAB™) monoclonal antibodies. (Full Press Release)
Rockville, Maryland —February 1st, 2011— OriGene Technologies, Inc., a gene-centric life sciences
company, releases the first commercially available full length human MTOR protein with superior biological activity.. (Full Press Release)